Pharmacokinetics of α-naphthyl isothiocyanate in rats

Journal of Pharmaceutical Sciences

Volumn 94, Issue 11, 2005, Pages 2441-2451

  Hu, Ke ^a   Morris, Marilyn E ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Absorption; Distribution; Excretion; Metabolism

Indexed keywords

1 NAPHTHYL ISOTHIOCYANATE; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CARCINOGENESIS; CHI SQUARE TEST; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG CLEARANCE; DRUG METABOLISM; FEMALE; NONHUMAN; RAT;

EID: 30544440323     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20460     Document Type: Article

References (25)

1. Hu K, Morris ME. 2004. Effects of benzyl-, phenethyl-, and alpha-naphthyl isothiocyanates on P-glycoprotein- and MRP1-mediated transport. J Pharm Sci 93:1901-1911.
2. Hecht SS. 2000. Inhibition of carcinogenesis by isothiocyanates. Drug Metab Rev 32:395-411.
3. Sasaki S. 1963. Inhibitory effects by a naphthylisothiocyanate on liver tumorigenesis in rats treated with 3′-methyl-4-dimethyl-aminoazobenzene. J Nat Med Assoc 14:101-115.
4. Sidransky H, Ito N, Verney E. 1966. Influence of alpha-naphthyl- isothiocyanate on liver tumorigenesis in rats ingesting ethionine and N-2-fluorenylacetamide. J Natl Cancer Inst 37:677-686.
5. Ito N, Hiasa Y, Konishi Y, Marugami M. 1969. The development of carcinoma in liver of rats treated with m-toluylenediamine and the synergistic and antagonistic effects with other chemicals. Cancer Res 29:1137-1145.
6. Lacassagne A, Hurst L, Xuong MD. 1970. [Inhibition by 2 naphtylisothiocyanates of hepatocarcinogenesis induced by p- dimethylaminoazobenzene (DAB) in rats]. C R Seances Soc Biol Fil 164:230-233.
7. Makiura S, Kamamoto Y, Sugihara S, Hirao K, Hiasa Y. 1973. Effect of 1-naphthyl isothiocyanate and 3-methylcholanthrene on hepatocarcinogenesis in rats treated with diethylnitrosoamine. Gann 64:101-104.
8. Zhang Y, Talalay P. 1994. Anticarcinogenic activities of organic isothiocyanates: Chemistry and mechanisms. Cancer Res 54:1976s-1981s.
9. Zhang Y, Talalay P. 1998. Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic Phase 2 enzymes. Cancer Res 58:4632-4639.
10. Hu R, Kim BR, Chen C, Hebbar V, Kong AN. 2003. The roles of JNK and apoptotic signaling pathways in PEITC-mediated responses in human HT-29 colon adenocarcinoma cells. Carcinogenesis 24:1361-1367.
11. Tseng E, Kamath A, Morris ME. 2002. Effect of organic isothiocyanates on the P-glycoprotein- and MRP1-mediated transport of daunomycin and vinblastine. Pharm Res 19:1509-1515.
12. Capizzo F, Roberts RJ. 1970. Disposition of the hepatotoxin alpha-naphthylisocyanate (ANIT) in the rats. Toxicol Appl Pharmacol 17:262-271.
13. Lock S, Witschi H, Skelton FS, Hanasono G, Plaa GL. 1974. Effect of cycloheximide on the distribution of alpha-naphthylisothiocyanate in rats. Exp Mol Pathol 21:237-245.
14. Connolly AK, Price SC, Stevenson D, Connelly JC, Hinton RH. 1988. Factors influencing the toxicity of alpha-naphthylisothiocyanate towards bile duct lining cells. Liver Cells Drugs 164:191-196.
15. Li Y, Yousef IM, Plaa GL. 1995. 1-Naphthyl isocyanate and 1-naphthylamine as metabolites of 1-naphthylisothiocyanate. Liver 15:271-275.
16. Carpenter-Deyo L, Marchand DH, Jean PA, Roth RA, Reed DJ. 1991. Involvement of glutathione in 1-naphthylisothiocyanate (ANIT) metabolism and toxicity to isolated hepatocytes. Biochem Pharmacol 42:2171-2180.
17. Jean PA, Roth RA. 1995. Naphthylisothlocyanate disposition in bile and its relationship to liver glutathione and toxicity. Biochem Pharmacol 50:1469-1474.
18. Jean PA, Bailie MB, Roth RA. 1995. 1-naphthylisothiocyanate-induced elevation of biliary glutathione. Biochem Pharmacol 49:197-202.
19. Hu K, Morris ME. 2003. Determination of alpha-naphthylisothiocyanate and metabolites alpha-naphthylamine and alpha-naphthylisocyanate in rat plasma and urine by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 788:17-28.
20. Capizzo F, Roberts RJ. 1971. Alpha-naphthylisothiocyanate (ANIT)-induced hepatotoxicity and disposition in various species. Toxicol Appl Pharmacol 19:176-187.
21. Breschi MC, Ducci M, Tacca M, Mazzanti L, Giusiani M, Poggi G, Palagi U. 1977. Distribution and fate of alpha-naphthl-isothiocyanate (ANIT) in the organs and body fluids of the rat. Arzneimittelforschung 27:122-126.
22. Dahm LJ, Roth RA. 1991. Protection against alpha-naphthylisothiocyanate- induced liver injury by decreased hepatic non-protein sulfhydryl content. Biochem Pharmacol 42:1181-1188.
23. Roth RA, Dahm LJ. 1997. Neutrophil- and glutathione-mediated hepatotoxicity of alpha-naphthylisothiocyanate. Drug Metab Rev 29:153-165.
24. Kruh GD, Belinsky MG. 2003. The MRP family of drug efflux pumps. Oncogene 22:7537-7552.
25. Dietrich CG, Ottenhoff R, de Waart DR, Oude Elferink RP. 2001. Role of MRP2 and GSH in intrahepatic cycling of toxins. Toxicology 167:73-81.